News + Filings Holdings
|
Paradigm Biocapital Advisors LP
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
Legend Biotech Corp
| LEGN | SPONSORED ADS | 1,805,717 | 295,393 | 124,648,645,000 | 51,820,822,000 | 9.63 | |
Hist
| 06/30/2023 |
INCYTE CORP
| INCY | Common | 1,381,711 | 120,000 | 86,011,510,000 | -5,172,344,000 | 6.65 | 0.62 |
Hist
| 06/30/2023 |
Immunocore Holdings plc
| IMCR | Common | 1,270,124 | 143,868 | 76,156,635,000 | 20,474,538,000 | 5.88 | |
Hist
| 06/30/2023 |
Arcellx, Inc.
| ACLX | Common | 2,347,000 | 589,221 | 74,212,140,000 | 20,054,969,000 | 5.73 | 4.89 |
Hist
| 06/30/2023 |
Karuna Therapeutics, Inc.
| KRTX | Common | 283,605 | 283,605 | 61,499,744,000 | 61,499,744,000 | 4.75 | 0.82 |
Hist
| 06/30/2023 |
Cerevel Therapeutics Holdings, Inc.
| CERE | Common | 1,868,946 | 273,747 | 59,413,793,000 | 20,506,889,000 | 4.59 | 1.19 |
Hist
| 06/30/2023 |
ARGENX SE
| ARGX | Put | 150,000 | 150,000 | 58,459,500,000 | 58,459,500,000 | 4.52 | |
Hist
| 06/30/2023 |
Viridian Therapeutics, Inc.\DE
| VRDN | COM | 2,415,256 | 329,558 | 57,458,940,000 | 4,398,783,000 | 4.44 | 5.60 |
Hist
| 06/30/2023 |
ARGENX SE
| ARGX | SPONSORED ADR | 142,259 | -38,913 | 55,442,600,000 | -12,058,464,000 | 4.28 | |
Hist
| 06/30/2023 |
UNITED THERAPEUTICS Corp
| UTHR | Common | 238,388 | 26,496 | 52,624,151,000 | 5,168,819,000 | 4.07 | 0.51 |
Hist
| 06/30/2023 |
Mirati Therapeutics, Inc.
| MRTX | COM | 1,443,762 | 46,983 | 52,163,121,000 | 230,878,000 | 4.03 | 2.48 |
Hist
| 06/30/2023 |
Syndax Pharmaceuticals Inc
| SNDX | Common | 2,424,132 | 149,620 | 50,737,083,000 | 2,699,390,000 | 3.92 | 3.52 |
Hist
| 06/30/2023 |
BICYCLE THERAPEUTICS plc
| BCYC | SPONSORED ADS | 1,985,430 | 168,649 | 50,668,174,000 | 12,025,242,000 | 3.92 | |
Hist
| 06/30/2023 |
Nuvalent, Inc.
| NUVL | Common | 1,120,465 | 1,120,465 | 47,250,009,000 | 47,250,009,000 | 3.65 | 1.97 |
Hist
| 06/30/2023 |
BeiGene, Ltd.
| BGNE | ADR | 216,093 | 32,081 | 38,529,382,000 | -1,130,724,000 | 2.98 | |
Hist
| 06/30/2023 |
Xenon Pharmaceuticals Inc.
| XENE | COM | 989,327 | 338,259 | 38,089,090,000 | 14,787,366,000 | 2.94 | 1.56 |
Hist
| 06/30/2023 |
Olema Pharmaceuticals, Inc.
| OLMA | Common | 3,731,046 | 1,348,669 | 33,691,345,000 | 25,424,497,000 | 2.60 | 9.15 |
Hist
| 06/30/2023 |
Ambrx Biopharma Inc.
| AMAM | SPONSORED ADS | 1,650,499 | 1,650,499 | 27,167,214,000 | 27,167,214,000 | 2.10 | |
Hist
| 06/30/2023 |
Crinetics Pharmaceuticals, Inc.
| CRNX | Common | 1,395,002 | 261,220 | 25,137,936,000 | 6,929,397,000 | 1.94 | 2.58 |
Hist
| 06/30/2023 |
ALPINE IMMUNE SCIENCES, INC.
| ALPN | Common | 2,423,961 | 106,327 | 24,918,319,000 | 7,026,185,000 | 1.93 | 5.05 |
Hist
| 06/30/2023 |
Vir Biotechnology, Inc.
| VIR | Common | 1,014,239 | 1,014,239 | 24,879,283,000 | 24,879,283,000 | 1.92 | 0.76 |
Hist
| 06/30/2023 |
Zai Lab Ltd
| ZLAB | Common | 865,297 | 84,739 | 23,994,686,000 | -1,966,673,000 | 1.85 | |
Hist
| 06/30/2023 |
Immatics N.V.
| IMTX | Common | 1,984,813 | 1,984,813 | 22,904,742,000 | 22,904,742,000 | 1.77 | 2.59 |
Hist
| 06/30/2023 |
Autolus Therapeutics plc
| AUTL | Common | 9,217,150 | 9,217,150 | 21,936,817,000 | 21,936,817,000 | 1.70 | 5.33 |
Hist
| 06/30/2023 |
Vor Biopharma Inc.
| VOR | Common | 6,461,467 | -16,532 | 19,965,933,000 | -14,885,702,000 | 1.54 | 9.65 |
Hist
| 06/30/2023 |
MADRIGAL PHARMACEUTICALS, INC.
| MDGL | Common | 85,000 | 85,000 | 19,635,000,000 | 19,635,000,000 | 1.52 | 0.46 |
Hist
| 06/30/2023 |
Verona Pharma plc
| VRNA | SPONSORED ADS | 893,861 | -68,500 | 18,896,222,000 | -427,987,000 | 1.46 | |
Hist
| 06/30/2023 |
MoonLake Immunotherapeutics
| MLTX | Common | 369,615 | 369,615 | 18,850,365,000 | 18,850,365,000 | 1.46 | 0.70 |
Hist
| 06/30/2023 |
Theseus Pharmaceuticals, Inc.
| THRX | Common | 1,950,327 | 445,000 | 18,196,551,000 | 4,829,247,000 | 1.41 | 4.48 |
Hist
| 06/30/2023 |
Kura Oncology, Inc.
| KURA | Common | 1,004,908 | 1,004,908 | 10,631,927,000 | 10,631,927,000 | 0.82 | 1.47 |
Hist
| 06/30/2023 |
Poseida Therapeutics, Inc.
| PSTX | Common | 0 | -1,072,410 | 0 | -3,303,023,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Keros Therapeutics, Inc.
| KROS | Common | 0 | -930,752 | 0 | -39,743,110,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Ascendis Pharma A/S
| ASND | SPONSORED ADR | 0 | -350,866 | 0 | -37,619,853,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
BIOGEN INC.
| BIIB | Common | 0 | -349,593 | 0 | -97,197,342,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Seagen Inc.
| SGEN | COM | 0 | -281,969 | 0 | -57,090,263,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
|
|
|